Amylase 30 UNT / cellulase 2 mg / hyoscyamine sulfate 0.0625 mg / lipase 1200 UNT / phenyltoloxamine 15 mg / protease 6 mg Oral Capsule [Gastrinex]
RxNorm 546610

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 546610 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: amylase 30 UNT / cellulase 2 mg / hyoscyamine sulfate 0.0625 mg / lipase 1200 UNT / phenyltoloxamine 15 mg / protease 6 mg Oral Capsule [Gastrinex].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBD
Amylase 30 UNT / cellulase 2 mg / hyoscyamine sulfate 0.0625 mg / lipase 1200 UNT / phenyltoloxamine 15 mg / protease 6 mg Oral Capsule [Gastrinex]
AUI:12364863

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBD

Semantic Branded Drug (SBD):
Amylase 30 UNT / cellulase 2 mg / hyoscyamine sulfate 0.0625 mg / lipase 1200 UNT / phenyltoloxamine 15 mg / protease 6 mg Oral Capsule [Gastrinex]
(Atom ID: 12364863)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
amylase 30 UNT / cellulase 2 MG / hyoscyamine sulfate 0.0625 MG / lipase 1200 UNT / phenyltoloxamine 15 MG / protease 6 MG Oral Capsule [Gastrinex]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
546610
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12364863
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
546610
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{329008} 33408
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{546604} 1225
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{329008} 33408
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{546604} 153970
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{329008} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{546604} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN OBSOLETED
04/30/2020
Date the RxNorm atom became obsolete
RXTERM FORM
Cap
The RxTerm dose form name for this drug